Berkshire Hathaway Revamps Portfolio With Major Stakes in Delta Air Lines and Alphabet Aluminum Price Surge Amid Iran Conflict Intensifies Cost Pressures for Major US Companies Balanced GrowthValue Strategy Gains Attention for MemoryChip Rally Play UK Food System Under Scrutiny as Price Cap Proposal Sparks Industry Backlash SpaceX Files for Stock Market Debut Ticker Could Be SPCX Potential to Make Elon Musk a Trillionaire SpaceX Launches Starship on Second Attempt Advancing NextGeneration Spaceflight Capabilities PRME Q1 2026 Earnings EPS Worse Than Expected as PreRevenue Biotech Advances Pipeline KLAR Q1 2026 Earnings Significant EPS Beat as Losses Narrow Sharply REX Q3 2001 Earnings Earnings Surpass Estimates with 23 Beat Stock Advances PETS Q1 2026 Earnings Severe EPS Miss Drives Stock Decline RRGB Q1 2026 Earnings Earnings Surprise Surpasses Expectations Stock Reacts Modestly UONE Q1 2026 Earnings Net Loss of 069 Per Share as Stock Drops 66 Iron Horse Acquisitions Corp II Rights IRHOR Edges Higher Amid Speculative Trading First Hawaiian FHB Dips 084 as Technical Indicators Point to Key Support Test Sila Realty Trust SILA Edges Higher as Price Hovers Near Support Key Levels to Watch NewHold Investment Corp III Warrants NHICW Surge Over 150 A HighVolatility Move Zhengye Biotechnology ZYBT Holds Near Key Support After Slight Decline Ofcom Flags Safety Concerns Over TikTok and YouTube for Younger Audiences Avnet Inc Q1 2026 Earnings Earnings Beat Driven by Solid EPS Surprise uCloudlink Group UCL Edges Higher Nears Resistance at 105 CTMX Q1 2026 Earnings Narrower Loss Exceeds Expectations as Pipeline Advances MFIC Q1 2026 Earnings EPS Beats Estimates Despite Negative Stock Reaction BLDR Q1 2026 Earnings EPS Misses Estimates by 284 Stock Edges Higher BMEA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction KGS Q1 2026 Earnings EPS Surpasses Estimates by 109 Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment